Found "Public health policy": 1,132 results
A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance
Abstract
Background
Antimicrobial resistance (AMR) is accelerated by the widespread and often indiscriminate use of antimicrobials in humans, animals, and the environment. In 2015, the World Health Organization recognised AMR as one of the top ten global health threats, due to its potential to n
Is it Worthwhile to Introduce Pneumococcal Conjugate Vaccine into the Routine Immunization Services?
In Bhutan, respiratory infections are some of the major causes of morbidity and mortality in children. Pneumonia, an infection of the lungs, is among the top 10 common
causes of children’s death in the country. Not only does it impose costs on society that may not be immediately visible (e.g. produ
High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand
Over the past 5 years, HCUs (i.e., top 5% of the population) utilized ~50% of the annual health expenditure, confirming that even during the pandemic year of 2020, the HCU phenomenon still existed.
The characteristics of HCU patients remained relatively the same from 2016 to 2020, in terms of pro
Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?
Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medicines (NLEM). This method can be used to assess the health value that new medicines will generate for patients after accounting for the health los
Cost-Effectiveness of Cascade Testing for Familial Hypercholesterolemia in Thailand: A Comparative Analysis of Genome Sequencing Methods Across Development Stages
Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated cholesterol levels, significantly increasing the risk of heart disease. Early detection through genetic screening can play a crucial role in preventing serious health outcomes.
This study marks the first global eco
Why do (and should) we do economic evaluation?
Every healthcare system in the world has to set priorities and make choices. Economic evaluation, in the context of health technology assessment, provides the decision makers with a framework for assessing the costs and benefits of various competing options, to inform fair and efficient use of limit
WHO Thailand visits HITAP
Dr. Daniel Kertesz, WHO Representative (WR) to Thailand and Dr. Liviu Vedrasco, Programme Officer WHO Thailand Country Office, visited the Health Intervention and Technology Assessment Program (HITAP) to learn about HITAP’s work in Thailand and the region as well as to discuss collaboration.Dr. Yot
HTA workshop in India on 3-5 October 2019
HITAP in collaboration with the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) is hosting a health technology assessment (HTA) workshop on 3-5 October 2019.In this workshop, the participants will learn:What is HTA?How can the value for money of a health intervention be
Final Report: Understanding the determinants and dynamics of access to maternal, newborn and child health care for migrants in Thailand along the Thai-Myanmar border
Undocumented pregnant women migrants and their young children are disproportionately affected by displacement and health system constraints. In Thailand, chronic gaps in financing and manpower resources challenge the sustainability of border health facilities to provide services to migrants. Kanchan
10 / Page